Amedisys Analyst Ratings
Amedisys Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
07/31/2023 | 11.24% | TD Cowen | $84 → $101 | Maintains | Market Perform |
07/27/2023 | 11.24% | Credit Suisse | → $101 | Reiterates | Neutral → Neutral |
07/06/2023 | 11.24% | Jefferies | $98 → $101 | Downgrades | Buy → Hold |
06/28/2023 | — | Benchmark | Downgrades | Buy → Hold | |
06/27/2023 | — | Benchmark | Downgrades | Buy → Hold | |
06/27/2023 | 11.24% | Truist Securities | $97 → $101 | Maintains | Hold |
06/07/2023 | 6.84% | Truist Securities | → $97 | Downgrades | Buy → Hold |
06/06/2023 | 10.14% | Cantor Fitzgerald | $91 → $100 | Maintains | Neutral |
06/06/2023 | 26.66% | Benchmark | → $115 | Reiterates | Buy → Buy |
06/06/2023 | 10.14% | Credit Suisse | $115 → $100 | Downgrades | Outperform → Neutral |
05/08/2023 | -7.48% | TD Cowen | $95 → $84 | Maintains | Market Perform |
05/05/2023 | -3.07% | Barclays | $93 → $88 | Maintains | Equal-Weight |
05/04/2023 | 6.84% | Truist Securities | $115 → $97 | Maintains | Buy |
05/04/2023 | 13.45% | Stephens & Co. | → $103 | Reiterates | → Equal-Weight |
04/21/2023 | -4.18% | Cantor Fitzgerald | → $87 | Initiates Coverage On | → Neutral |
04/13/2023 | 26.66% | Truist Securities | $130 → $115 | Maintains | Buy |
03/14/2023 | 26.66% | Benchmark | → $115 | Reiterates | → Buy |
03/14/2023 | 13.45% | Stephens & Co. | → $103 | Reiterates | → Equal-Weight |
03/13/2023 | 2.43% | Barclays | → $93 | Initiates Coverage On | → Equal-Weight |
02/27/2023 | 26.66% | Credit Suisse | → $115 | Reiterates | → Outperform |
02/21/2023 | 22.26% | RBC Capital | $114 → $111 | Maintains | Outperform |
02/16/2023 | 4.64% | Stephens & Co. | → $95 | Reiterates | → Equal-Weight |
02/16/2023 | 26.66% | Benchmark | $120 → $115 | Maintains | Buy |
02/13/2023 | 32.17% | Benchmark | → $120 | Reiterates | → Buy |
01/25/2023 | 32.17% | Benchmark | $135 → $120 | Maintains | Buy |
01/23/2023 | 26.66% | Credit Suisse | $140 → $115 | Maintains | Outperform |
01/19/2023 | 37.68% | Oppenheimer | $145 → $125 | Maintains | Outperform |
01/05/2023 | -6.38% | SVB Leerink | $96 → $85 | Maintains | Market Perform |
11/11/2022 | 16.75% | Stephens & Co. | $122 → $106 | Maintains | Equal-Weight |
11/01/2022 | 5.74% | SVB Leerink | $116 → $96 | Maintains | Market Perform |
11/01/2022 | 34.37% | Stephens & Co. | $105 → $122 | Maintains | Equal-Weight |
10/31/2022 | 53.1% | RBC Capital | $165 → $139 | Maintains | Outperform |
10/28/2022 | 38.78% | Barclays | $154 → $126 | Maintains | Overweight |
10/28/2022 | 15.65% | Stephens & Co. | $120 → $105 | Maintains | Equal-Weight |
10/28/2022 | 43.19% | Truist Securities | $140 → $130 | Maintains | Buy |
10/28/2022 | 59.71% | Oppenheimer | $175 → $145 | Maintains | Outperform |
10/27/2022 | — | Raymond James | Downgrades | Outperform → Market Perform | |
10/24/2022 | 81.74% | Deutsche Bank | $175 → $165 | Maintains | Buy |
10/05/2022 | 54.2% | Truist Securities | $150 → $140 | Maintains | Buy |
10/03/2022 | 48.69% | Benchmark | $165 → $135 | Maintains | Buy |
08/02/2022 | 4.64% | UBS | $145 → $95 | Downgrades | Neutral → Sell |
08/01/2022 | 54.2% | Raymond James | $180 → $140 | Maintains | Outperform |
07/29/2022 | 69.62% | Barclays | $181 → $154 | Maintains | Overweight |
07/28/2022 | 81.74% | Benchmark | $175 → $165 | Maintains | Buy |
07/14/2022 | 65.21% | Truist Securities | $175 → $150 | Maintains | Buy |
06/29/2022 | 40.98% | Stifel | → $128 | Initiates Coverage On | → Hold |
06/21/2022 | 12.35% | B of A Securities | $145 → $102 | Downgrades | Neutral → Underperform |
06/21/2022 | 92.75% | Deutsche Bank | $210 → $175 | Maintains | Buy |
06/21/2022 | 92.75% | Truist Securities | $200 → $175 | Maintains | Buy |
06/21/2022 | 37.68% | Stephens & Co. | $155 → $125 | Maintains | Equal-Weight |
06/21/2022 | 17.85% | SVB Leerink | $117 → $107 | Maintains | Market Perform |
05/27/2022 | 28.87% | SVB Leerink | $131 → $117 | Maintains | Market Perform |
04/29/2022 | 100.46% | Credit Suisse | $181 → $182 | Maintains | Outperform |
04/29/2022 | 98.26% | Raymond James | $200 → $180 | Maintains | Outperform |
04/29/2022 | 44.29% | SVB Leerink | $162 → $131 | Maintains | Market Perform |
03/01/2022 | 85.04% | UBS | $152 → $168 | Upgrades | Sell → Neutral |
02/25/2022 | 114.78% | Credit Suisse | $200 → $195 | Maintains | Outperform |
02/25/2022 | 120.29% | Oppenheimer | $225 → $200 | Maintains | Outperform |
02/25/2022 | 109.27% | BMO Capital | → $190 | Upgrades | Market Perform → Outperform |
02/24/2022 | 92.75% | Benchmark | $200 → $175 | Maintains | Buy |
02/18/2022 | 61.91% | SVB Leerink | $145 → $147 | Maintains | Market Perform |
12/21/2021 | 134.6% | Barclays | $236 → $213 | Maintains | Overweight |
11/08/2021 | 147.82% | Raymond James | $250 → $225 | Maintains | Outperform |
11/04/2021 | 125.79% | Credit Suisse | $192 → $205 | Maintains | Outperform |
11/04/2021 | 103.76% | Stephens & Co. | $178 → $185 | Maintains | Equal-Weight |
11/04/2021 | 143.42% | RBC Capital | $244 → $221 | Maintains | Outperform |
11/04/2021 | 99.36% | SVB Leerink | $170 → $181 | Maintains | Market Perform |
11/03/2021 | 147.82% | Oppenheimer | $265 → $225 | Maintains | Outperform |
10/13/2021 | 109.27% | Truist Securities | $255 → $190 | Maintains | Buy |
09/27/2021 | 87.24% | SVB Leerink | → $170 | Initiates Coverage On | → Market Perform |
09/24/2021 | 65.21% | UBS | → $150 | Initiates Coverage On | → Sell |
09/10/2021 | 114.78% | Cowen & Co. | → $195 | Initiates Coverage On | → Market Perform |
08/11/2021 | 175.36% | Credit Suisse | $330 → $250 | Maintains | Outperform |
08/10/2021 | 158.84% | Benchmark | $325 → $235 | Maintains | Buy |
08/10/2021 | 175.36% | Raymond James | $325 → $250 | Maintains | Outperform |
08/06/2021 | 191.88% | Oppenheimer | $325 → $265 | Maintains | Outperform |
08/06/2021 | 161.04% | Stephens & Co. | $310 → $237 | Maintains | Equal-Weight |
08/05/2021 | 142.31% | B of A Securities | → $220 | Downgrades | Buy → Neutral |
02/23/2021 | 257.96% | Benchmark | $275 → $325 | Maintains | Buy |
02/08/2021 | 274.49% | Deutsche Bank | $275 → $340 | Maintains | Buy |
10/30/2020 | 208.4% | Credit Suisse | $246 → $280 | Maintains | Outperform |
09/21/2020 | 186.37% | Oppenheimer | $250 → $260 | Maintains | Outperform |
09/02/2020 | 197.39% | BMO Capital | $250 → $270 | Maintains | Market Perform |
07/30/2020 | 197.39% | SunTrust Robinson Humphrey | $260 → $270 | Maintains | Buy |
07/30/2020 | 180.86% | Raymond James | $210 → $255 | Maintains | Outperform |
07/30/2020 | 186.37% | Deutsche Bank | $220 → $260 | Maintains | Buy |
07/30/2020 | 175.36% | Benchmark | $210 → $250 | Maintains | Buy |
07/30/2020 | 186.37% | RBC Capital | $218 → $260 | Maintains | Outperform |
07/29/2020 | 175.36% | Jefferies | $225 → $250 | Maintains | Buy |
07/10/2020 | 186.37% | SunTrust Robinson Humphrey | $240 → $260 | Maintains | Buy |
06/18/2020 | 131.3% | Benchmark | → $210 | Upgrades | Hold → Buy |
05/21/2020 | 164.34% | SunTrust Robinson Humphrey | $225 → $240 | Maintains | Buy |
05/11/2020 | 109.27% | UBS | $208 → $190 | Maintains | Neutral |
05/11/2020 | 131.3% | Raymond James | $225 → $210 | Maintains | Outperform |
03/09/2020 | 125.79% | Benchmark | → $205 | Upgrades | Hold → Buy |
02/21/2020 | 129.1% | UBS | $154 → $208 | Maintains | Neutral |
02/21/2020 | 120.29% | Stephens & Co. | $180 → $200 | Maintains | Equal-Weight |
02/20/2020 | 147.82% | SunTrust Robinson Humphrey | $185 → $225 | Maintains | Buy |
02/20/2020 | 147.82% | Raymond James | $200 → $225 | Maintains | Outperform |
01/17/2020 | 126.89% | Credit Suisse | → $206 | Initiates Coverage On | → Outperform |
01/03/2020 | 120.29% | Raymond James | $144 → $200 | Maintains | Outperform |
12/18/2019 | 103.76% | SunTrust Robinson Humphrey | $175 → $185 | Maintains | Buy |
12/06/2019 | 87.24% | BMO Capital | → $170 | Initiates Coverage On | → Market Perform |
11/26/2019 | 96.05% | B of A Securities | $170 → $178 | Maintains | Buy |
11/20/2019 | 87.24% | B of A Securities | $163 → $170 | Reiterates | → Buy |
11/07/2019 | 69.62% | UBS | $144 → $154 | Maintains | Neutral |
11/01/2019 | — | Baird | Upgrades | Neutral → Outperform | |
10/22/2019 | 59.71% | Stephens & Co. | → $145 | Reinstates | → Equal-Weight |
09/17/2019 | 70.72% | Deutsche Bank | → $155 | Initiates Coverage On | → Buy |
08/05/2019 | 37.68% | Barclays | $120 → $125 | Maintains | Equal-Weight |
07/15/2019 | 58.61% | Raymond James | $140 → $144 | Maintains | Outperform |
05/02/2019 | 54.2% | Raymond James | → $140 | Upgrades | Market Perform → Outperform |
03/21/2019 | 32.17% | Barclays | $115 → $120 | Maintains | Equal-Weight |
02/05/2019 | — | Benchmark | Downgrades | Buy → Hold | |
12/14/2018 | 43.19% | Barclays | → $130 | Initiates Coverage On | → Equal-Weight |
11/16/2018 | 38.78% | UBS | → $126 | Initiates Coverage On | → Neutral |
10/30/2018 | — | Benchmark | Upgrades | Hold → Buy | |
10/26/2018 | 14.55% | Craig-Hallum | $116 → $104 | Downgrades | Buy → Hold |
10/11/2018 | 32.17% | Baird | $105 → $120 | Maintains | Neutral |
10/11/2018 | 37.68% | Cantor Fitzgerald | $117 → $125 | Maintains | Neutral |
09/18/2018 | 53.1% | B of A Securities | $116 → $139 | Maintains | Buy |
09/13/2018 | 28.87% | Cantor Fitzgerald | → $117 | Initiates Coverage On | → Neutral |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
07/31/2023 | 11.24% | TD Cowen | $84→$101 | 維護 | 市場表現 |
07/27/2023 | 11.24% | 瑞士信貸 | →$101 | 重申 | 中性→中性 |
07/06/2023 | 11.24% | 傑富瑞 | $98→$101 | 評級下調 | 購買→Hold |
2023年6月28日 | - | 基準 | 評級下調 | 購買→Hold | |
2023年6月27日 | - | 基準 | 評級下調 | 購買→Hold | |
2023年6月27日 | 11.24% | Truist證券 | $97→$101 | 維護 | 保持 |
06/07/2023 | 6.84% | Truist證券 | →$97 | 評級下調 | 購買→Hold |
06/06/2023 | 10.14% | 康託·菲茨傑拉德 | $91→$100 | 維護 | 中性 |
06/06/2023 | 26.66% | 基準 | →$115 | 重申 | 購買→購買 |
06/06/2023 | 10.14% | 瑞士信貸 | $115→$100 | 評級下調 | 跑贏→中性 |
05/08/2023 | -7.48% | TD Cowen | $95→$84 | 維護 | 市場表現 |
05/05/2023 | -3.07% | 巴克萊 | $93→$88 | 維護 | 等重 |
05/04/2023 | 6.84% | Truist證券 | $115→$97 | 維護 | 買 |
05/04/2023 | 13.45% | 斯蒂芬斯公司 | →$103 | 重申 | →等重 |
04/21/2023 | -4.18% | 康託·菲茨傑拉德 | →$87 | 開始承保 | →中性 |
04/13/2023 | 26.66% | Truist證券 | $130→$115 | 維護 | 買 |
03/14/2023 | 26.66% | 基準 | →$115 | 重申 | →購買 |
03/14/2023 | 13.45% | 斯蒂芬斯公司 | →$103 | 重申 | →等重 |
03/13/2023 | 2.43% | 巴克萊 | →$93 | 開始承保 | →等重 |
02/27/2023 | 26.66% | 瑞士信貸 | →$115 | 重申 | →跑贏大盤 |
02/21/2023 | 22.26% | 加拿大皇家銀行資本 | $114→$111 | 維護 | 跑贏大盤 |
02/16/2023 | 4.64% | 斯蒂芬斯公司 | →$95 | 重申 | →等重 |
02/16/2023 | 26.66% | 基準 | $120→$115 | 維護 | 買 |
02/13/2023 | 32.17% | 基準 | →$120 | 重申 | →購買 |
2023年1月25日 | 32.17% | 基準 | $135→$120 | 維護 | 買 |
2023年1月23日 | 26.66% | 瑞士信貸 | $140→$115 | 維護 | 跑贏大盤 |
2023年1月19日 | 37.68% | 奧本海默 | $145→$125 | 維護 | 跑贏大盤 |
01/05/2023 | -6.38% | SVB Leerink | $96→$85 | 維護 | 市場表現 |
2022年11月11日 | 16.75% | 斯蒂芬斯公司 | $122→$106 | 維護 | 等重 |
11/01/2022 | 5.74% | SVB Leerink | $116→$96 | 維護 | 市場表現 |
11/01/2022 | 34.37% | 斯蒂芬斯公司 | $105→$122 | 維護 | 等重 |
2022年10月31日 | 53.1% | 加拿大皇家銀行資本 | $165→$139 | 維護 | 跑贏大盤 |
10/28/2022 | 38.78% | 巴克萊 | $154→$126 | 維護 | 超重 |
10/28/2022 | 15.65% | 斯蒂芬斯公司 | $120→$105 | 維護 | 等重 |
10/28/2022 | 43.19% | Truist證券 | $140→$130 | 維護 | 買 |
10/28/2022 | 59.71% | 奧本海默 | $175→$145 | 維護 | 跑贏大盤 |
10/27/2022 | - | 雷蒙德·詹姆斯 | 評級下調 | 跑贏→市場表現 | |
10/24/2022 | 81.74% | 德意志銀行 | $175→$165 | 維護 | 買 |
10/05/2022 | 54.2% | Truist證券 | $150→$140 | 維護 | 買 |
10/03/2022 | 48.69% | 基準 | $165→$135 | 維護 | 買 |
08/02/2022 | 4.64% | 瑞銀集團 | $145→$95 | 評級下調 | 中性→銷售 |
08/01/2022 | 54.2% | 雷蒙德·詹姆斯 | $180→$140 | 維護 | 跑贏大盤 |
07/29/2022 | 69.62% | 巴克萊 | $181→$154 | 維護 | 超重 |
07/28/2022 | 81.74% | 基準 | $175→$165 | 維護 | 買 |
07/14/2022 | 65.21% | Truist證券 | $175→$150 | 維護 | 買 |
2022/06/29 | 40.98% | Stifel | →$128 | 開始承保 | →保留 |
2022年06月21日 | 12.35% | B of A證券 | $145→$102 | 評級下調 | 中性→表現不佳 |
2022年06月21日 | 92.75% | 德意志銀行 | $210→$175 | 維護 | 買 |
2022年06月21日 | 92.75% | Truist證券 | $200→$175 | 維護 | 買 |
2022年06月21日 | 37.68% | 斯蒂芬斯公司 | $155→$125 | 維護 | 等重 |
2022年06月21日 | 17.85% | SVB Leerink | $117→$107 | 維護 | 市場表現 |
2022年05月27日 | 28.87% | SVB Leerink | $131→$117 | 維護 | 市場表現 |
04/29/2022 | 100.46% | 瑞士信貸 | $181→$182 | 維護 | 跑贏大盤 |
04/29/2022 | 98.26% | 雷蒙德·詹姆斯 | $200→$180 | 維護 | 跑贏大盤 |
04/29/2022 | 44.29% | SVB Leerink | $162→$131 | 維護 | 市場表現 |
03/01/2022 | 85.04% | 瑞銀集團 | $152→$168 | 升級 | 賣出→中性 |
02/25/2022 | 114.78% | 瑞士信貸 | $200→$195 | 維護 | 跑贏大盤 |
02/25/2022 | 120.29% | 奧本海默 | $225→$200 | 維護 | 跑贏大盤 |
02/25/2022 | 109.27% | 蒙特利爾銀行資本 | →$190 | 升級 | 市場表現優於→ |
02/24/2022 | 92.75% | 基準 | $200→$175 | 維護 | 買 |
02/18/2022 | 61.91% | SVB Leerink | $145→$147 | 維護 | 市場表現 |
2021/12/21 | 134.6% | 巴克萊 | $236→$213 | 維護 | 超重 |
11/08/2021 | 147.82% | 雷蒙德·詹姆斯 | $250→$225 | 維護 | 跑贏大盤 |
11/04/2021 | 125.79% | 瑞士信貸 | $192→$205 | 維護 | 跑贏大盤 |
11/04/2021 | 103.76% | 斯蒂芬斯公司 | $178→$185 | 維護 | 等重 |
11/04/2021 | 143.42% | 加拿大皇家銀行資本 | $244→$221 | 維護 | 跑贏大盤 |
11/04/2021 | 99.36% | SVB Leerink | $170→$181 | 維護 | 市場表現 |
11/03/2021 | 147.82% | 奧本海默 | $265→$225 | 維護 | 跑贏大盤 |
10/13/2021 | 109.27% | Truist證券 | $255→$190 | 維護 | 買 |
09/27/2021 | 87.24% | SVB Leerink | →$170 | 開始承保 | →市場表現 |
09/24/2021 | 65.21% | 瑞銀集團 | →$150 | 開始承保 | →銷售 |
09/10/2021 | 114.78% | 考恩公司 | →$195 | 開始承保 | →市場表現 |
2021/08/11 | 175.36% | 瑞士信貸 | $330→$250 | 維護 | 跑贏大盤 |
2021/08/10 | 158.84% | 基準 | $325→$235 | 維護 | 買 |
2021/08/10 | 175.36% | 雷蒙德·詹姆斯 | $325→$250 | 維護 | 跑贏大盤 |
08/06/2021 | 191.88% | 奧本海默 | $325→$265 | 維護 | 跑贏大盤 |
08/06/2021 | 161.04% | 斯蒂芬斯公司 | $310→$237 | 維護 | 等重 |
08/05/2021 | 142.31% | B of A證券 | →$220 | 評級下調 | 購買→中性 |
02/23/2021 | 257.96% | 基準 | $275→$325 | 維護 | 買 |
02/08/2021 | 274.49% | 德意志銀行 | $275→$340 | 維護 | 買 |
10/30/2020 | 208.4% | 瑞士信貸 | $246→$280 | 維護 | 跑贏大盤 |
2020/09/21 | 186.37% | 奧本海默 | $250→$260 | 維護 | 跑贏大盤 |
09/02/2020 | 197.39% | 蒙特利爾銀行資本 | $250→$270 | 維護 | 市場表現 |
07/30/2020 | 197.39% | SunTrust Robinson Humphrey | $260→$270 | 維護 | 買 |
07/30/2020 | 180.86% | 雷蒙德·詹姆斯 | $210→$255 | 維護 | 跑贏大盤 |
07/30/2020 | 186.37% | 德意志銀行 | $220→$260 | 維護 | 買 |
07/30/2020 | 175.36% | 基準 | $210→$250 | 維護 | 買 |
07/30/2020 | 186.37% | 加拿大皇家銀行資本 | $218→$260 | 維護 | 跑贏大盤 |
07/29/2020 | 175.36% | 傑富瑞 | $225→$250 | 維護 | 買 |
07/10/2020 | 186.37% | SunTrust Robinson Humphrey | $240→$260 | 維護 | 買 |
06/18/2020 | 131.3% | 基準 | →$210 | 升級 | 持有→購買 |
2020/05/21 | 164.34% | SunTrust Robinson Humphrey | $225→$240 | 維護 | 買 |
05/11/2020 | 109.27% | 瑞銀集團 | $208→$190 | 維護 | 中性 |
05/11/2020 | 131.3% | 雷蒙德·詹姆斯 | $225→$210 | 維護 | 跑贏大盤 |
03/09/2020 | 125.79% | 基準 | →$205 | 升級 | 持有→購買 |
02/21/2020 | 129.1% | 瑞銀集團 | $154→$208 | 維護 | 中性 |
02/21/2020 | 120.29% | 斯蒂芬斯公司 | $180→$200 | 維護 | 等重 |
02/20/2020 | 147.82% | SunTrust Robinson Humphrey | $185→$225 | 維護 | 買 |
02/20/2020 | 147.82% | 雷蒙德·詹姆斯 | $200→$225 | 維護 | 跑贏大盤 |
2020/01/17 | 126.89% | 瑞士信貸 | →$206 | 開始承保 | →跑贏大盤 |
1/03/2020 | 120.29% | 雷蒙德·詹姆斯 | $144→$200 | 維護 | 跑贏大盤 |
2019年12月18日 | 103.76% | SunTrust Robinson Humphrey | $175→$185 | 維護 | 買 |
2019年6月12日 | 87.24% | 蒙特利爾銀行資本 | →$170 | 開始承保 | →市場表現 |
2019年11月26日 | 96.05% | B of A證券 | $170→$178 | 維護 | 買 |
2019年11月20日 | 87.24% | B of A證券 | $163→$170 | 重申 | →購買 |
2019/07/11 | 69.62% | 瑞銀集團 | $144→$154 | 維護 | 中性 |
2019/11/01 | - | 貝爾德 | 升級 | 中性→表現優異 | |
2019年10月22日 | 59.71% | 斯蒂芬斯公司 | →$145 | 恢復 | →等重 |
2019/09/17 | 70.72% | 德意志銀行 | →$155 | 開始承保 | →購買 |
2019年08月05日 | 37.68% | 巴克萊 | $120→$125 | 維護 | 等重 |
2019年07月15日 | 58.61% | 雷蒙德·詹姆斯 | $140→$144 | 維護 | 跑贏大盤 |
2019年05月02日 | 54.2% | 雷蒙德·詹姆斯 | →$140 | 升級 | 市場表現優於→ |
2019年03月21日 | 32.17% | 巴克萊 | $115→$120 | 維護 | 等重 |
2019年05月02日 | - | 基準 | 評級下調 | 購買→Hold | |
2018年12月14日 | 43.19% | 巴克萊 | →$130 | 開始承保 | →等重 |
2018年11月16日 | 38.78% | 瑞銀集團 | →$126 | 開始承保 | →中性 |
2018年10月30日 | - | 基準 | 升級 | 持有→購買 | |
2018年10月26日 | 14.55% | 克雷格-哈勒姆 | $116→$104 | 評級下調 | 購買→Hold |
2018年10月11日 | 32.17% | 貝爾德 | $105→$120 | 維護 | 中性 |
2018年10月11日 | 37.68% | 康託·菲茨傑拉德 | $117→$125 | 維護 | 中性 |
2018年09月18日 | 53.1% | B of A證券 | $116→$139 | 維護 | 買 |
2018年09月13日 | 28.87% | 康託·菲茨傑拉德 | →$117 | 開始承保 | →中性 |
What is the target price for Amedisys (AMED)?
Amedisys(Amed)的目標價是多少?
The latest price target for Amedisys (NASDAQ: AMED) was reported by TD Cowen on July 31, 2023. The analyst firm set a price target for $101.00 expecting AMED to rise to within 12 months (a possible 11.24% upside). 42 analyst firms have reported ratings in the last year.
TD Cowen於2023年7月31日報道了Amedisys(納斯達克代碼:AMED)的最新目標價。這家分析公司將目標價定為101.00美元,預計Amed將在12個月內上漲至11.24%(可能上漲11.24%)。去年有42家分析公司公佈了評級。
What is the most recent analyst rating for Amedisys (AMED)?
Amedisys(Amed)的最新分析師評級是多少?
The latest analyst rating for Amedisys (NASDAQ: AMED) was provided by TD Cowen, and Amedisys maintained their market perform rating.
TD Cowen提供了對Amedisys(納斯達克代碼:AMED)的最新分析師評級,Amedisys維持其市場表現評級。
When is the next analyst rating going to be posted or updated for Amedisys (AMED)?
Amedisys(Amed)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Amedisys, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Amedisys was filed on July 31, 2023 so you should expect the next rating to be made available sometime around July 31, 2024.
分析師在進行了廣泛的研究後得出了股票評級,其中包括查閱公共財務報表,與Amedisys的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。Amedisys的上一次評級是在2023年7月31日提交的,所以你應該預計下一次評級將在2024年7月31日左右的某個時候公佈。
Is the Analyst Rating Amedisys (AMED) correct?
分析師對Amedisys(Amed)的評級正確嗎?
While ratings are subjective and will change, the latest Amedisys (AMED) rating was a maintained with a price target of $84.00 to $101.00. The current price Amedisys (AMED) is trading at is $90.79, which is within the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的Amedisys(AMED)評級維持不變,目標價在84美元至101.00美元之間。Amedisys(Amed)目前的交易價格為90.79美元,在分析師的預測區間內。
譯文內容由第三人軟體翻譯。